View Post Raltegravir: The First in a New Class of Integrase Inhibitors for the Treatment of HIV. Expert Review of Anti-Infective Therapy, 6(4): 419-426. In by AHFAugust 16, 2008
View Post Hepatitis C Patients’ Self-Reported Adherence to Treatment with Pegylated Interferon and Ribavirin. Alimentary Pharmacology & Therapeutics, 28: 289-293. In by AHFAugust 15, 2008
View Post Hepatitis C Patients’ Self-Reported Adherence to Treatment with Pegylated Interferon and Ribavirin. Alimentary Pharmacology and Therapeutics, 28: 289-293. In by AHFJuly 1, 2008
View Post False-Positivity of HIV-2 Immunoblots in a Cohort of Elite Suppressors Infected with HIV-1. Journal of Acquired Immune Deficiency Syndromes, 47(5): 644. In by AHFApril 1, 2008
View Post Darunavir: A New HIV-1 Protease Inhibitor for the Treatment of HIV Infection. Future HIV Therapy, 2(2): 125-136. In by AHFMarch 16, 2008
View Post Efficacy and Safety of Once-Daily Darunavir/Ritonavir Versus Lopinavir/Ritonavir in Treatment-Naive HIV-1-Infected Patients at Week 48. AIDS, 22(12): 1389-1397. In by AHFMarch 1, 2008
View Post Implementing Rapid HIV Testing in Outreach and Community Settings: Results from an Advancing HIV Prevention Demonstration Project Conducted in Seven U.S. Cities. Public Health Reports, 123: 78-85. In by AHFJanuary 15, 2008
View Post Pediatric HIV Infection: The State of Antiretroviral Therapy. Expert Review of Anti-Infective Therapy, 6(2): 167-180. In by AHFJanuary 1, 2008
View Post HIV Care and Treatment for Children in Resource-Limited Settings. Expert Review of Anti-Infective Therapy, 6: 181-190. In by AHFJanuary 1, 2008
View Post An Exploratory Study of Long-Term Neurocognitive Outcomes Following Recovery from Opportunistic Brain Infections in HIV+ Adults. Journal of Clinical and Experimental Neuropsychology, 30(7): 836-843. In by AHFNovember 16, 2007
